Drug class
Phosphodiesterase 4 Inhibitor
Mechanism of action
Phosphodiesterase 4 Inhibitors [MoA]
General use cases
- Arthritis, Psoriatic
- adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with active psoriatic arthritis
- adult patients and pediatric patients 6 years of age and older and weighing at least 50 kg with active psoriatic arthritis
- adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy
- pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
